These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 31216201
1. Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI. Bajgiran AM, Mirak SA, Sung K, Sisk AE, Reiter RE, Raman SS. AJR Am J Roentgenol; 2019 Sep; 213(3):W134-W142. PubMed ID: 31216201 [Abstract] [Full Text] [Related]
2. Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology. Boesen L, Chabanova E, Løgager V, Balslev I, Thomsen HS. J Magn Reson Imaging; 2015 Aug; 42(2):446-53. PubMed ID: 25408104 [Abstract] [Full Text] [Related]
3. Multiparametric MRI in detection and staging of prostate cancer. Boesen L. Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066 [Abstract] [Full Text] [Related]
4. Quantitative evaluation of the relative apparent diffusion coefficient values on multiparametric magnetic resonance imaging to predict higher Gleason score prostate cancer. Kato S, Kamijima S, Inaoka T, Kamiya N, Sasai D, Terada H, Hiruta N, Suzuki H. Scand J Urol; 2018 Jun; 52(3):180-185. PubMed ID: 29939084 [Abstract] [Full Text] [Related]
5. Comparison of quantitative apparent diffusion coefficient parameters with prostate imaging reporting and data system V2 assessment for detection of clinically significant peripheral zone prostate cancer. Hassanzadeh E, Alessandrino F, Olubiyi OI, Glazer DI, Mulkern RV, Fedorov A, Tempany CM, Fennessy FM. Abdom Radiol (NY); 2018 May; 43(5):1237-1244. PubMed ID: 28840280 [Abstract] [Full Text] [Related]
8. Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings. Karaarslan E, Altan Kus A, Alis D, Karaarslan UC, Saglican Y, Argun OB, Kural AR. Diagn Interv Radiol; 2022 Jan; 28(1):12-20. PubMed ID: 35142611 [Abstract] [Full Text] [Related]
9. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer. Cindil E, Oner Y, Sendur HN, Ozdemir H, Gazel E, Tunc L, Cerit MN. Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925 [Abstract] [Full Text] [Related]
11. Diffusion Kurtosis Imaging Combined With DWI at 3-T MRI for Detection and Assessment of Aggressiveness of Prostate Cancer. Wang X, Tu N, Qin T, Xing F, Wang P, Wu G. AJR Am J Roentgenol; 2018 Oct; 211(4):797-804. PubMed ID: 30085835 [Abstract] [Full Text] [Related]
13. Correlation of apparent diffusion coefficient ratio on 3.0 T MRI with prostate cancer Gleason score. Jyoti R, Jain TP, Haxhimolla H, Liddell H, Barrett SE. Eur J Radiol Open; 2018 Oct; 5():58-63. PubMed ID: 29687050 [Abstract] [Full Text] [Related]
14. Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI. Hötker AM, Mazaheri Y, Aras Ö, Zheng J, Moskowitz CS, Gondo T, Matsumoto K, Hricak H, Akin O. AJR Am J Roentgenol; 2016 Apr; 206(4):756-63. PubMed ID: 26900904 [Abstract] [Full Text] [Related]